MAPK/MAK/MRK overlapping kinase
MAPK/MAK/MRK overlapping kinase (11-20) is a synthetic peptide fragment corresponding to amino acid residues 11 through 20 of the MAPK/MAK/MRK overlapping kinase (MOK) protein sequence. As a member of the serine/threonine kinase family, MOK is implicated in a variety of cellular signaling processes, particularly those involved in cell cycle regulation, proliferation, and differentiation. The (11-20) peptide region is of interest for researchers studying kinase-substrate interactions, post-translational modifications, and the structural determinants of kinase activity. Its defined sequence and biochemical relevance make it a valuable tool for dissecting the molecular mechanisms underpinning MAPK-related signaling cascades.
Peptide substrate studies: The (11-20) peptide serves as a model substrate for in vitro kinase assays, enabling researchers to investigate the phosphorylation activity and substrate specificity of MAPK/MAK/MRK family kinases. By employing this defined peptide fragment, scientists can monitor kinase-mediated phosphorylation events, quantify enzymatic activity, and characterize the influence of cofactors or inhibitors on kinase function. This application is crucial for elucidating the regulatory mechanisms governing signal transduction pathways in cellular models.
Antibody production and validation: The sequence corresponding to residues 11-20 of MOK is often utilized as an immunogen for generating polyclonal or monoclonal antibodies specific to the kinase or its phosphorylated forms. These antibodies are essential for detecting endogenous or recombinant MOK in immunoblotting, immunoprecipitation, or immunohistochemical applications. Using a well-characterized peptide antigen enhances the specificity and sensitivity of antibody-based detection methods, facilitating high-resolution studies of kinase expression and localization.
Protein-protein interaction mapping: Researchers employ the (11-20) peptide to probe and map interaction domains within the MAPK/MAK/MRK overlapping kinase or its binding partners. By incorporating the peptide into pull-down assays or affinity chromatography workflows, it is possible to identify and characterize proteins that interact with this region, providing insights into the assembly and regulation of signaling complexes. Such studies contribute to a deeper understanding of the functional networks orchestrated by serine/threonine kinases.
Epitope mapping and structural analysis: The defined sequence of the peptide fragment is instrumental in epitope mapping studies, where it helps delineate antibody binding sites or regions involved in molecular recognition. In structural biology, the peptide can be used in crystallization trials or NMR experiments to resolve conformational features relevant to kinase activation or substrate recognition. These approaches support the rational design of inhibitors and modulators targeting the MAPK/MAK/MRK kinase family.
Cell signaling pathway research: Employing the (11-20) peptide in cellular assays allows for the functional interrogation of MAPK/MAK/MRK-related pathways. By introducing the peptide as a competitive inhibitor or as a probe for downstream signaling events, researchers can dissect the roles of specific kinase domains in modulating cellular responses to external stimuli. This application aids in clarifying the contribution of distinct sequence motifs to the regulation of complex signaling networks, advancing the broader understanding of cell physiology and signal integration.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More